ArticleFrontiers in immunology2024

Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study.

Zhitao Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.